CEA

Dome Construction Awarded Its 21st CEA Excellence in Safety and 8th President’s Awards

Retrieved on: 
Tuesday, March 19, 2024
Commercial Building & Real Estate, Construction & Property, Building Systems, REIT, Construction, CEA, Pharmaceutical industry

Dome Construction , one of California’s leading general contractors, today announced it won two awards from the Construction Employers’ Association (CEA), the Excellence in Safety award for the 21st year in a row and the President’s Safety Award for the 5th year in a row, its 8th time overall.

Key Points: 
  • Dome Construction , one of California’s leading general contractors, today announced it won two awards from the Construction Employers’ Association (CEA), the Excellence in Safety award for the 21st year in a row and the President’s Safety Award for the 5th year in a row, its 8th time overall.
  • The Excellence in Safety Award winners have achieved both a total incident rate and a lost workday incident rate 25 percent below the industry average, an experience modification rate below 1.0, a flat or negative experience modification trend over the past four years, and a demonstration of an active safety training program.
  • The President’s Safety Award recognizes CEA member firms whose safety programs exceed industry standards.
  • President’s Safety Award winners are recognized for having achieved both a total injury and incident rate and a lost workday rate at least 50 percent below the industry average, and an experience modification rate of .70 or less.

BITB Crosses $2 Billion in Assets, Generates Largest Inflows of Any Crypto Specialist1

Retrieved on: 
Monday, March 11, 2024
Professional Services, Technology, Blockchain, Cryptocurrency, Fintech, Digital Cash Management, Digital Assets, Bitcoin, Russian National Wealth Fund, Theft, Health, Organization, Valkyrie, ETF, Risk, BITB, Share, History, NAV, SMA, Rest, IPO, Life, Lovell Minnick Partners, Loss, Marketing, Prospectus, RIAS, Investment, Fraud, Ecosystem, Commodity Exchange Act, Fund, CEA

Today, over 3,000 wealth teams, RIAs, family offices, and institutional clients trust Bitwise as their specialist partner in the crypto space.

Key Points: 
  • Today, over 3,000 wealth teams, RIAs, family offices, and institutional clients trust Bitwise as their specialist partner in the crypto space.
  • Bitwise’s national team of crypto experts is available to meet with investment professionals any time and in person.
  • Bitwise’s product offerings include five other crypto-themed ETFs, the world’s largest crypto index fund, private placement funds, alpha solutions, and separately managed account (SMA) solutions.
  • As of March 8, 2024, Bitwise has experienced net inflows of $1.35 billion, Valkyrie has experienced net inflows of $264 million, and Grayscale has experienced net outflows of more than $10 billion.

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Retrieved on: 
Wednesday, April 3, 2024
Monocyte, GM, Serum, Disease, Partnership, Patient, GM-CSF, DNA, PTX, Doctor of Philosophy, Respiratory failure, Pleasure, Trade name, Granulocyte-macrophage colony-stimulating factor, Pulmonary fibrosis, APAP, Therapy, Niigata University, Pulmonary alveolar proteinosis, Division, Partner, PMDA, PAGE, CEA, WLL, Hospital

LEXINGTON, Mass., April 3, 2024 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx) announced that its partner Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device Agency (PMDA) for the inhaled use of Leukine (sargramostim), branded in Japan as Sargmalin, to treat aPAP. PTx licensed rights for certain indications in Japan to Nobelpharma in 2022. Leukine is a glycosylated recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) produced by recombinant DNA technology in yeast. Leukine is not approved outside Japan for aPAP or as an inhalation therapy. Partner Therapeutics will manufacture Sargmalin for Nobelpharma at its manufacturing facility in Lynnwood, WA.

Key Points: 
  • Leukine is not approved outside Japan for aPAP or as an inhalation therapy.
  • Partner Therapeutics will manufacture Sargmalin for Nobelpharma at its manufacturing facility in Lynnwood, WA.
  • Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients.
  • Autoimmune pulmonary alveolar proteinosis.

Local Bounti Announces Full Year 2023 Financial Results

Retrieved on: 
Wednesday, March 27, 2024
USDA, Growth, Plant, Acceleration, Patent, Webcast, Research, Sale, Acquisition, Capital, Depreciation, Grab, Pacific Northwest, CEA, Modern Greek, Economics, Weather

"2023 was a defining year for Local Bounti, culminating in significantly expanded production capacity following the implementation of our now patented Stack & Flow Technology and optimization of our Georgia facility," stated Craig Hurlbert, CEO of Local Bounti.

Key Points: 
  • "2023 was a defining year for Local Bounti, culminating in significantly expanded production capacity following the implementation of our now patented Stack & Flow Technology and optimization of our Georgia facility," stated Craig Hurlbert, CEO of Local Bounti.
  • With the facility now fully scaled, Local Bounti is focused on satisfying existing demand from retailers across the southeastern U.S.
  • As of December 31, 2023, Local Bounti had approximately 8.3 million shares outstanding, 6.2 million common shares under warrants outstanding, and approximately 0.7 million restricted stock units outstanding.
  • The Company will host a conference call with members of the Local Bounti executive management team.

Minister LeBlanc introduces legislation to further strengthen Canada's electoral process

Retrieved on: 
Wednesday, March 20, 2024
Element, Public security, Democracy, Commissioner, Publishing, Artificial intelligence, Policy, Deepfake, Disclosure, Parliament, Elections Canada, Canada Elections Act, Privacy, Collection, CEA

The CEA is the fundamental legislative framework that regulates Canada's electoral process.

Key Points: 
  • The CEA is the fundamental legislative framework that regulates Canada's electoral process.
  • It is independently administered by the Chief Electoral Officer and Elections Canada, with compliance and enforcement by the Commissioner of Canada Elections.
  • Recent experiences and lessons from the 2019 and 2021 general elections highlighted opportunities to further remove barriers to voting and encourage voter participation, protect personal information, and strengthen electoral safeguards.
  • To recognize the growing demand and lessons learned, the special ballot process would be improved from start to finish.

NM Holding, Nature’s Miracle and Lakeshore Acquisition II Corp. Announce Closing of Business Combination

Retrieved on: 
Monday, March 11, 2024
Acquisition, Controlled-environment agriculture, CEA, Upland, California, LLP, LBBB

Upland, CA, March 11, 2024 (GLOBE NEWSWIRE) -- Nature’s Miracle Holding Inc. (“the Company”), Nature’s Miracle, Inc. (“Nature’s Miracle”), a growing Controlled Environment Agriculture (CEA) technology company, and Lakeshore Acquisition II Corp., a special purpose acquisition company (Nasdaq: LBBB) (“Lakeshore”), announced today the closing of their previously announced business combination (the “Transaction”).

Key Points: 
  • Upland, CA, March 11, 2024 (GLOBE NEWSWIRE) -- Nature’s Miracle Holding Inc. (“the Company”), Nature’s Miracle, Inc. (“Nature’s Miracle”), a growing Controlled Environment Agriculture (CEA) technology company, and Lakeshore Acquisition II Corp., a special purpose acquisition company (Nasdaq: LBBB) (“Lakeshore”), announced today the closing of their previously announced business combination (the “Transaction”).
  • The Company will be led by Tie (James) Li, the Chairman of the Board and Chief Executive Officer, along with George Yutuc as the Chief Financial Officer.
  • Maxim Group LLC acted as the exclusive financial advisor to Lakeshore in connection with the Transaction.
  • Sichenzia Ross Ference Carmel LLP acted as legal counsel to Nature’s Miracle.

Edible Garden to Showcase Pulp Sustainable Line of Gourmet Sauces and Chili-Based Products Including Additional New Products at Natural Products EXPO WEST® 2024 in Anaheim, California, March 14th-16th

Retrieved on: 
Thursday, March 7, 2024
CEA, EXPO, Whole Foods Market, Nature, Human, Food court, Condiment, National Organic Program, Edible, Dierbergs Markets, Target, Fast food

BELVIDERE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, announced that the Company will showcase its new line of Pulp sustainable gourmet sauces and chili-based products at the National Products EXPO WEST® 2024, booth #5274 in Anaheim, California from Thursday, March 14th  to Saturday, March 16th.

Key Points: 
  • National Products EXPO WEST® 2024 is produced by New Hope Network and co-located by Fresh Ideas Organic Marketplace.
  • The event annually attracts 60,000 to 65,000 participants with buyers constituting roughly 60% of the total.
  • The event will highlight the latest in natural and organic food and drink, eco-friendly beauty, and household items, as well as supplements and ingredients.
  • Mr. Jim Kras, Chief Executive Officer of Edible Garden, commented, "We are excited to be back at EXPO WEST and showcase the Pulp line of sustainable gourmet sauces and chili-based products at EXPO WEST® 2024.

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Wednesday, March 6, 2024
CMS, Pi, Growth, Radiology, IDE, State university system, CAD, Buffalo, PMA, MDR, TEL, Medical device regulation, Health, Stroke, CAS, TCAR, EPS, EFS, Thomas Jefferson University, European, Carotid artery stenosis, Myocardial infarction, CE marking, Vascular disease, Thrombectomy, Clinical trial, Medicaid, NPS, CEA, Good Samaritan Hospital, Stenosis, Risk, Blood vessel, Medicare, Death, Stent, Patient, Medicine, NSPR, Pharmaceutical industry

TEL AVIV, Israel and MIAMI, March 06, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced financial and operating results for the fourth quarter and full-year ended December 31, 2023.

Key Points: 
  • Fourth Quarter 2023 and Recent Developments:
    Generated record CGuard revenue in the fourth quarter 2023 of $1.76 million, a 71.6% increase over the fourth quarter of 2022.
  • Sold 3,107 CGuard EPS stent systems in the fourth quarter of 2023, as compared to 1,781 in the fourth quarter of 2022, an increase of 74.5%.
  • Financial Results for the Fourth Quarter Ended December 31, 2023
    For the fourth quarter of 2023, total revenue increased 71.6%, to $1,761,000, from $1,026,000 during the fourth quarter of 2022.
  • Total financial income for the fourth quarter of 2023 was $468,000, an increase of $349,000 or 293% compared to $119,000 for the third quarter of 2022.

Edible Garden Announces Appointment of Chanida Curnutt as Senior Vice President of Business Development and Compliance

Retrieved on: 
Tuesday, March 5, 2024
Senior, CEA, Investment, Growth, Food, Business development, Commerce, Health, LLM, Georgetown University Law Center, LLB, Edible, Agriculture, Chulalongkorn University

BELVIDERE, NJ, March 05, 2024 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, today announced that Chanida Curnutt has been appointed Senior Vice President of Business Development and Compliance.

Key Points: 
  • BELVIDERE, NJ, March 05, 2024 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, today announced that Chanida Curnutt has been appointed Senior Vice President of Business Development and Compliance.
  • Ms. Curnutt brings more than 13 years of experience in global business and transaction strategies, international trade and commerce, corporate governance, and regulatory compliance.
  • Mr. Jim Kras, Chief Executive Officer of Edible Garden, commented, “We are extremely pleased to welcome Chanida Curnutt to the Edible Garden team.
  • Furthermore, we believe that her comprehensive experience and insights into the Southeast Asian market will be invaluable as Edible Garden leverages international expansion opportunities.

Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System

Retrieved on: 
Tuesday, March 5, 2024
FACS, Hospital, MD, CEA, Professor, Physician, Vascular surgery, Stroke, Plaque, MBA, Risk, Cooper University Hospital, Silk, Patient, Anatomy, TCAR, Stenosis, SILK, Pharmaceutical industry

This launch expands upon the company’s prior ENROUTE Transcarotid Stent System, offering additional configurations to better tailor the Transcarotid Artery Revascularization (TCAR) procedure to patient anatomy.

Key Points: 
  • This launch expands upon the company’s prior ENROUTE Transcarotid Stent System, offering additional configurations to better tailor the Transcarotid Artery Revascularization (TCAR) procedure to patient anatomy.
  • “New tapered configurations for our ENROUTE Transcarotid Stent System build upon the robust portfolio of Silk Road’s carotid solutions.
  • The ENROUTE Transcarotid Stent System features an optimized cell design balancing lesion coverage and anatomical conformability for long-term plaque stabilization.
  • The stent system was purpose-built for TCAR with a short delivery system for ergonomic and precise stent delivery.